Dimensional Fund Advisors
AYTU icon

Dimensional Fund Advisors’s AYTU BioPharma AYTU Stock Holding History

Dimensional Fund Advisors’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119K Buy
43,585
+8,222
+23% +$21K ﹤0.01% 3104
2025
Q4 		$91.9K Buy
35,363
+4,399
+14% +$9.87K ﹤0.01% 3160
2025
Q3 		$58.2K Buy
+30,964
New +$71.6K ﹤0.01% 3232
2025
Q1 		– Sell
-10,926
Closed -$18.2K – 3328
2024
Q4 		$18.2K Sell
10,926
-10,906
-50% -$19.9K ﹤0.01% 3327
2024
Q3 		$51.3K Sell
21,832
-1,719
-7% -$4.45K ﹤0.01% 3297
2024
Q2 		$68.5K Buy
23,551
+8,311
+55% +$25.1K ﹤0.01% 3288
2024
Q1 		$46.3K Buy
+15,240
New +$43.6K ﹤0.01% 3337
2023
Q2 		– Sell
-47,263
Closed -$106K – 3485
2023
Q1 		$106K Buy
+47,263
New +$138K ﹤0.01% 3294

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors's AYTU Position: Q1 2026 in Review

Dimensional Fund Advisors increased its AYTU BioPharma (AYTU) stake by 23% in Q1 2026, buying an estimated $21K and bringing the position to 43,585 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #3104.

Dimensional Fund Advisors first reported a position in AYTU in Q1 2023 and has held it in 8 quarters since. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

  • Dimensional Fund Advisors held 43,585 shares of AYTU BioPharma worth $119K as of Q1 2026.
  • Dimensional Fund Advisors bought 8,222 AYTU BioPharma shares in Q1 2026, an estimated $21K.
  • AYTU BioPharma made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3104 holding.
  • Dimensional Fund Advisors first reported a position in AYTU BioPharma in Q1 2023 and has held it in 8 quarters since.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.